Recombinant human albumin in cell culture: Evaluation of growth-promoting potential for NRK and SCC-9 cells in vitro

Cytotechnology

Volumn 24, Issue 3, 1997, Pages 243-252

  Keenan, J ^a   Dooley, M ^a   Pearson, D ^b   Clynes, M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b Delta Biotechnology Ltd   (United Kingdom)

Author keywords

Growth promoting activity; Human serum albumin; Lipid loading; NRK; Recombinant human albumin; SCC 9

Indexed keywords

EID: 0030988797     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007916930200     Document Type: Article

References (33)

1. Anderson SN, Ruben Z and Fuller GC (1990) Cell-mediated contraction of collagen lattices in serum-free medium. In Vitro 26: 61-66.
2. Ashbrook JD, Spector AA and Fletcher JE (1972) Medium chain fatty acid binding to human plasma albumin. J. Biol. Chem. 247: 7030-7042.
3. Ashbrook JD, Spector AA, Santos EC (1975) Long-chain fatty acid binding to human plasma albumin. J. Biol. Chem. 250: 2333-38.
4. Barlian A and Bols N (1991) Identification of bovine serum albumins that support salmonoid cell proliferation in the absence of serum. In Vitro 27a.: 439-441.
5. Brown JR and Shockley P (1982) In: 'Lipid-Protein Interactions' P Jost and OH Griffith (eds) Vol. 1, pp. 25-68, New York.
6. Congote LF (1987) Extraction of an erythrotropin-like factor from bovine serum albumin (Cohn fraction V). In Vitro 23: 361-366.
7. Díaz-Gil JJ, Gavilanes JG, Sánchez G, García-Cañero R, García-Segura JM, Santamaría L, Trilla C and Escartín (1987) Identification of a liver growth factor as an albumin-bilirubin complex. Biochem. J. 243: 443-448.
8. Drouin R, Harvey P, Richer CL, Remy-Prince S and Montplaisir S (1987) Human serum albumin as a substitute for foetal calf serum in blast transformation assays and cytogenetic analyses. Cytobios 52: 193-207.
9. Gerschenson LE, Mead JF, Harary I and Haggerty DF Jr (1967) Studies on the effects of essential fatty acids on growth rate, fatty acid composition, oxidative phosphorylation and respiratory control of HeLa cells in culture. Biochem. Biophys. Acta. 131: 42-49.
10. Glassy CM, Tharakan JP and Chau PC (1988) Serum-free media in Hybridoma culture and monoclonal antibody production. Biotech. and Bioeng. 32: 1015-1028.
11. Ham RG (1963) Albumin replacement by fatty acids in clonal growth of mammalian cells. Science 140: 802-803.
12. Ham RG and McKeehan WL (1978) Media and growth requirements. In: WB Jakoby and IH Pastar (eds), Methods in Enzymology, pp. 44-93, Vol LVIII, Cell culture, Academic Press Inc.
13. Ham RG, St Clair JA, Webster C and Blau HM (1988) Improved media for normal human muscle satellite cells: serum-free clonal growth and enhanced growth with low serum. In Vitro 24, 833-844.
14. Hatzinger PB and Stevens JL (1989) Rat kidney proximal tubule defined medium: the roles of cholera toxin, extracellular calcium and serum in cell growth and expression of gamma- glutamyl-transferase. In Vitro 25, 205-212.
15. Hewlett G, Duvinski MS and Montalto JG (1989) PENTEX EXCYTE Growth Enhancement Media Supplement as a Lipoprotein Additive for Mammalian Cell Culture. Miles Science J(Elkhart, IN) 11(1): 9-14.
16. Hodgson J (1990) BSE scares up a host of sourcing worries. Bio/technology 8: 990.
17. Iscove NN, Guilbert LJ and Weyman C (1980) Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acids, lecithin and cholesterol. Exp. Cell. Res. 126: 121-126.
18. Jäger V, Lehmann J and Friedl P (1988) Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors. Cytotechnology 1: 319-329.
19. Kane M (1990) Control of growth in pre-implantation embryos. IJMS January, 17-21.
20. Keenan J, Doherty G and Clynes M (1995) Use of reverse-phase HPLC to isolate bioactivity from BSA. J Experimental and Clinical Cancer Research 14: 65-67.
21. Keenan J, Doherty G and Clynes M (1996) Separation of growth-stimulating activity of BS A fraction V from the bulk of albumin using Heparin Sepharose. Cytotechnology 19: 63-72.
22. Kiss C (1990) Clonal growth and renewal of human myeloid leukemia cell lines (BRM and DD) in serum-free semi-solid culture. Blut. 61: 317-319.
23. Kragh-Hansen U (1981) Effects of aliphatic fatty acids on the binding of phenol red to Human Serum Albumin. Biochem. J. 195: 603-613.
24. Martin A and Clynes (1991) Acid phosphatase: Endpoint for in vitro toxicity tests. In Vitro 27a: 183-184.
25. Miyasaki M, Bai L and Namba M (1991) Extending effect of phospholipids, cholesterol, and ethanolamines on survival of adult rat hepatocytes in serum-free primary culture. Res. Exp. Med. 191: 77-83.
26. Nilausen K (1978) Role of fatty acids in growth-promoting effect of serum albumin on hamster cells in vitro. J Cell Physiol 96: 1-14.
27. Peters T (1970) Serum albumin. Adv. Clin. Chem. 13: 37-111.
28. Shaklai N, Garlick RL and Bunn HF (1984) Nonenzymatic glycosylation of Human Serum Albumin alters its conformation and function. J. Biol. Chem. 259: 3812-3817.
29. Smith SM, Draper ME and Houghton RG (1990) Growth of BHK21 C113 Suspension Cells in Low Serum Medium Supplemented with PENTEX EX-CYTE III. European Society for Animal Cell Technology meeting, Avignon France, May 11.
30. Soliman HA and Olesen H (1976) Folic acid binding by Human Plasma albumin. Scand. J. Clin. Lab. Invest. 36: 299-304.
31. Szejtli J (1986) Cyclodextrins in Biotechnology. Stärke 38: 388-390.
32. Tigyi G and Miledi R (1992) Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus Oocytes and neurite retraction in PC12 pheochromoctyoma cells. J. Biol. Chem. 26: 21360-21367.
33. Unger WG (1972) Binding of Prostaglandin to Human Serum Albumin. J. Pharm. Pharmacol. 24: 470-477.